[0] TRSG Announces New Product Line.Business Editors LAS VEGAS--(BUSINESS WIRE)--Oct. 25, 2001 TRSG Corp. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: TSGO) a majority-owned subsidiary majority-owned subsidiary A firm in which more than 50% of outstanding voting stock is owned by the parent company. of Gateway Distributors Ltd. (OTC BB: GTWY GTWY Gateway ), Thursday announced it has begun the sales and marketing of hand-held, low-cost devices used to detect the presence of biological agents such as Bacillus bacillus (bəsĭl`əs), any rod-shaped bacterium or, more particularly, a rod-shaped bacterium of the genus Bacillus. Some bacterium in the genus cause disease, for example B. Anthraci (commonly referred to as Anthrax) as well as many other biological agents. These detection devices are designed specifically for home or small office use and are priced between $50 and $100 per unit. The company's new Biological Agent Detection Product utilizes UV-A UV-A or UVA Noun ultraviolet radiation with a range of 320-380 nanometres waves or waves in the 320 to 380 nm range, commonly referred to as black light or wood's light, that have been determined to not cause sunburn sunburn, inflammation of the skin caused by actinic rays from the sun or artificial sources. Moderate exposure to ultraviolet radiation is followed by a red blush, but severe exposure may result in blisters, pain, and constitutional symptoms. to human skin though the use of eye protection is recommended during use. These products are for detection purposes only and are not intended as a treatment or cure for any specific disease. Ongoing research is being conducted at this time to verify the product's effectiveness in the use of identifying the presence of a wide range of biological agents such as Becillus Anthraci, which is currently making headlines across the country. Independent research laboratories are conducting this research. Additional information regarding these studies can be found on the following Web sites: http://www.potomacinstitute.org/pubs/advtech.pdf http://www.potomacinstitute.org/press/transitpolicing.htm http://www.hhmi.org/grants/lectures/biointeractive/web_video/ hantavirus hantavirus, any of a genus (Hantavirus) of single-stranded RNA viruses that are carried by rodents and transmitted to humans when they inhale vapors from contaminated rodent urine, saliva, or feces. There are many strains of hantavirus. .htm http://www.cdc.gov/ncidod/dbmd/diseaseinfo/anthrax_g.htm TRSG Corp. ("TRSG" or "the company") believes that it will be able to use its domestic as well as international marketing structure to market and distribute this new line of products directly to the consumer and office market place using its more then 14,000 independent distributors. The company believes it will benefit from the current need of business and consumers to seek higher levels of protection from potential biological agent contamination from unknown parties and can effectively compete with companies such as, Cepheid (Nasdaq:CPHD CPHD Cepheid Inc (stock symbol) CPHD Combined Pituitary Hormone Deficiency CPHD Certified Philanthropic Development (National Association of Charitable Estate Counselors) ) and Bruker Daltonics (Nasdaq: BDAL BDAL Battle Doll Angelic Layer (game) ). With target retail prices of between $50 and $100 per unit, these hand-held products will offer consumers and small businesses a viable solution to address current Anthrax concerns. This additional product line will provide an area of diversification for the company from its health and dietary products currently being marketed and provide an additional source for income for the company and its marketing forces. Gateway Distributors Ltd. and its subsidiary TRSG are in the business of selling health and environmentally safe products throughout North America, Russia, and Japan. TRSG believes sales of these products will have a significant positive effect on the overall company's revenues. Ordering information and procedures can be found on the company's Web site www.rightsolution.com. A number of statements contained in this press release are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development, and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions and the ability to secure additional sources of financing. The actual results that TRSG may achieve could differ materially from any forward-looking statements due to such risks and uncertainties. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion